【结 构 式】 |
【分子编号】48101 【品名】(E)-2-(5-chloro-2-thienyl)-1-ethenesulfonyl chloride 【CA登记号】 |
【 分 子 式 】C6H4Cl2O2S2 【 分 子 量 】243.13396 【元素组成】C 29.64% H 1.66% Cl 29.16% O 13.16% S 26.38% |
合成路线1
该中间体在本合成路线中的序号:(V)The lithium anion of ethyl methanesulfonate (I) was condensed with ethyl chlorophosphonate to produce the phosphonate (II), which was subsequently subjected to a Wittig reaction with 5-chlorotiophene-2-carboxaldehyde (III), yielding olefin (IV). After cleavage of the ethyl sulfonate of (IV) by means of tetrabutylammonium iodide, treatment with sulfuryl chloride afforded the intermediate sulfonyl chloride (V).
【2】 Myers, M.R.; Becker, M.R.; Ewing, W.R.; Spada, A.P. (Aventis Pharmaceuticals, Inc.); Substd. oxoazaheterocyclyl factor Xa inhibitors. WO 0032590; WO 0107436 . |
【1】 Hanney, B.A.; He, W.; Poli, G.B.; Spada, A.P.; Myers, M.R.; Burns, C.J.; Pauls, H.W.; Jiang, J.Z.; Condon, S.M.; Ewing, W.R.; Becker, M.R.; Li, A.; Choi-Sledeski, Y.M.; Lau, W.F.; Davis, R.S. (Aventis Pharmaceuticals, Inc.); Substd. oxoazaheterocyclyl factor Xa inhibitors. EP 1051176; WO 9937304 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 48097 | ethyl methanesulfonate;ethylmesylate;ethyl methanesulphonate;O-ethylmethylsulfonate | 62-50-0 | C3H8O3S | 详情 | 详情 |
(II) | 48098 | ethyl (diethoxyphosphoryl)methanesulfonate | C7H17O6PS | 详情 | 详情 | |
(III) | 48099 | 5-chloro-2-thiophenecarbaldehyde | 7283-96-7 | C5H3ClOS | 详情 | 详情 |
(IV) | 48100 | ethyl (E)-2-(5-chloro-2-thienyl)-1-ethenesulfonate | C8H9ClO3S2 | 详情 | 详情 | |
(V) | 48101 | (E)-2-(5-chloro-2-thienyl)-1-ethenesulfonyl chloride | C6H4Cl2O2S2 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(V)Coupling of piperazinone (XIV) with sulfonyl chloride (V) gave rise to the sulfonamide (XV). The N-Boc group of (XV) was finally cleaved by treatment with trifluoroacetic acid to afford the title compound.
【2】 Myers, M.R.; Becker, M.R.; Ewing, W.R.; Spada, A.P. (Aventis Pharmaceuticals, Inc.); Substd. oxoazaheterocyclyl factor Xa inhibitors. WO 0032590; WO 0107436 . |
【1】 Hanney, B.A.; He, W.; Poli, G.B.; Spada, A.P.; Myers, M.R.; Burns, C.J.; Pauls, H.W.; Jiang, J.Z.; Condon, S.M.; Ewing, W.R.; Becker, M.R.; Li, A.; Choi-Sledeski, Y.M.; Lau, W.F.; Davis, R.S. (Aventis Pharmaceuticals, Inc.); Substd. oxoazaheterocyclyl factor Xa inhibitors. EP 1051176; WO 9937304 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(V) | 48101 | (E)-2-(5-chloro-2-thienyl)-1-ethenesulfonyl chloride | C6H4Cl2O2S2 | 详情 | 详情 | |
(XIV) | 48108 | tert-butyl 2-[(2-oxo-1-piperazinyl)methyl]-1H-pyrrolo[3,2-c]pyridine-1-carboxylate | C17H22N4O3 | 详情 | 详情 | |
(XV) | 48109 | tert-butyl 2-[(4-[[(E)-2-(5-chloro-2-thienyl)ethenyl]sulfonyl]-2-oxo-1-piperazinyl)methyl]-1H-pyrrolo[3,2-c]pyridine-1-carboxylate | C23H25ClN4O5S2 | 详情 | 详情 |